These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29574922)

  • 1. Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.
    Cuker A
    Am J Hematol; 2018 Jun; 93(6):816-823. PubMed ID: 29574922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment.
    Ghanima W; Gernsheimer T; Kuter DJ
    Blood; 2021 May; 137(20):2736-2744. PubMed ID: 33827138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment outcome of immune thrombocytopenia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2012 Oct; 153(41):1613-21. PubMed ID: 23045311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of refractory primary immune thrombocytopenia.
    Moulis G; Garabet L
    Br J Haematol; 2023 Oct; 203(1):112-118. PubMed ID: 38019080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reference guide for the treatment of adult idiopathic thrombocytopenic purpura].
    Kashiwagi H
    Rinsho Ketsueki; 2020; 61(9):1325-1330. PubMed ID: 33162532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of treatments for adults with primary immune thrombocytopenia.
    George JN
    Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.
    Vianelli N; Auteri G; Buccisano F; Carrai V; Baldacci E; Clissa C; Bartoletti D; Giuffrida G; Magro D; Rivolti E; Esposito D; Podda GM; Palandri F
    Ann Hematol; 2022 May; 101(5):963-978. PubMed ID: 35201417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia.
    Lozano ML; Godeau B; Grainger J; Matzdorff A; Rodeghiero F; Hippenmeyer J; Kuter DJ
    Expert Rev Hematol; 2020 Dec; 13(12):1319-1332. PubMed ID: 33249935
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
    Rodrigo C; Gooneratne L
    J Thromb Haemost; 2013 Nov; 11(11):1946-53. PubMed ID: 23927583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune thrombocytopenia: no longer 'idiopathic'.
    McCrae K
    Cleve Clin J Med; 2011 Jun; 78(6):358-73. PubMed ID: 21632906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of primary immune thrombocytopenia in adults.
    Ejaz A; Radia D
    Br J Hosp Med (Lond); 2019 Apr; 80(4):C54-C57. PubMed ID: 30951423
    [No Abstract]   [Full Text] [Related]  

  • 12. ITP and international guidelines: what do we know, what do we need?
    Rodeghiero F; Ruggeri M
    Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura.
    Veneri D; Soligo L; Pizzolo G; Ambrosetti A
    Blood Transfus; 2015 Oct; 13(4):694-5. PubMed ID: 26057496
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombopoietin receptor agonists as second-line therapy in splenectomy-eligible persistent immune thrombocytopenia: a case series.
    Vianello F; D'Amore F; Lombardi AM; Caputo I; Friziero A; Da Dalt G
    Blood Coagul Fibrinolysis; 2019 Sep; 30(6):295-299. PubMed ID: 31259778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary immune thrombocytopenia].
    Wehrli M; Goede JS
    Praxis (Bern 1994); 2014 Apr; 103(9):485-94; quiz 495-6. PubMed ID: 24755495
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of ITP].
    Yokoyama K
    Rinsho Ketsueki; 2021; 62(8):1229-1235. PubMed ID: 34497211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
    Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenectomy in ITP: we keep removing a healthy functional organ.
    Anguita E; Candel FJ; González-Del Castillo J; Martín-Sánchez FJ
    Ann Hematol; 2016 Oct; 95(11):1911-2. PubMed ID: 27577110
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune thrombocytopenia in adults: an update.
    Thota S; Kistangari G; Daw H; Spiro T
    Cleve Clin J Med; 2012 Sep; 79(9):641-50. PubMed ID: 22949345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
    Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.